TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTC: TOBAF)
(FRANKFURT: 2TP2) (the “Company” or “Taat”) is pleased to
announce that it has released an updated corporate video, narrated
by CEO Setti Coscarella with supplemental footage of in-house
refinement of Beyond Tobacco™ base material, as well as production
and packaging of the Beyond Tobacco™ product. In the video, Mr.
Coscarella provides an overview of his path from the tobacco
industry to Taat, a recap of the Company’s achievements to date
under his administration, and a summary of the Company’s next steps
in introducing Beyond Tobacco™ to the retail market in the United
States.
The Company has developed Beyond Tobacco™, a tobacco-flavoured
combustible product that is nicotine-free and tobacco-free,
designed to offer a user experience closely resembling that of
smoking a tobacco cigarette. According to the World Health
Organization, 1.3 billion people worldwide use tobacco1. Despite
this incidence rate, many tobacco users aspire to leave nicotine
behind. Based on 2018 data from the CDC, 55.1% of adult smokers had
attempted to quit in the past year, though only 7.5% successfully
quit smoking in that timeframe2. A factor that is commonly
attributed to tobacco smokers’ abandonment of alternative products
such as vaping is the unfamiliar format which lacks the
sensorimotor components of smoking a tobacco cigarette. These
components play a significant role in the “ritual” of smoking
cigarettes. Beyond Tobacco™ has been meticulously engineered to
mimic these components, allowing current tobacco smokers of legal
age to enjoy a substantially similar ritual by using Beyond
Tobacco™ in place of a traditional cigarette, while refraining from
nicotine intake.
In Taat’s new corporate video, Mr. Coscarella explains how
during his time as a strategist in the tobacco industry it was a
fundamental objective to understand the likes and dislikes of
tobacco smokers. This understanding was then used to shape a
consumer journey from combustible tobacco cigarettes to smokeless
products. While the tobacco industry has relied on the delivery of
nicotine without combustion as the central value proposition of
smokeless products, Mr. Coscarella explains in the video why the
combustible format and corresponding ritual are crucial to gaining
product adoption and preventing abandonment. Taat’s new corporate
video can be watched by clicking the image below, and can also be
accessed by clicking here. Readers using news aggregation services
may be unable to access the corporate video link. As an
alternative method of accessing Taat’s updated corporate video, the
Company has posted the video to its profiles on Facebook and
Twitter.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/b5d96934-0aaf-4390-a1e5-8d2c49ea28da.
For clarity, product and manufacturing footage in Taat’s new
corporate video was captured prior to the completion of provisional
new pack designs for Beyond Tobacco™, which were released to the
public in a press release dated September 29, 2020. The Company
anticipates that finalized new pack designs will appear in Taat’s
next corporate video update.
Taat CEO Setti Coscarella commented, “In just two months as CEO
of Taat, I believe we have made considerable progress in preparing
Beyond Tobacco™ to be the best it can be, and establishing our
go-to-market approach to align the product with the shopping
patterns of current legal-aged smokers of tobacco cigarettes.
Releasing this video is an important part of our messaging, as it
reflects exactly where the Company is today compared to where it
was when our original corporate video was published in early July
2020. We now have an improved product, a patent application filed
for our base material refinement method, commercial-scale
production with a North American contract manufacturer who produces
for national and regional tobacco cigarette brands, and a former
‘Big Tobacco’ commercialization executive as our Chief Revenue
Officer. Now that we are in Q4 2020, we are very excited to share
new developments as they materialize leading up to the mid-Q4 2020
Beyond Tobacco™ launch in the United States.”
Sources:
1 - https://www.who.int/news-room/fact-sheets/detail/tobacco
2 -
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/smoking-cessation-fast-facts/index.html
On behalf of the Board of Directors of the Company,
TAAT LIFESTYLE & WELLNESS LTD.
“Setti Coscarella”
Setti Coscarella, CEO
For further information, please contact:
Mauricio Inzunza1-833-TAAT-USA
(1-833-822-8872)investor@taatusa.com
THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES
NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS
RELEASE.
About Taat Lifestyle & Wellness Ltd.
Having developed Beyond Tobacco™, which contains no tobacco or
nicotine, Taat’s objective is to introduce an innovative,
experience-driven alternative to tobacco cigarettes for tobacco
smokers who aspire to leave nicotine behind. Beyond Tobacco™, which
is to be offered in “Original” and “Menthol” varieties, is designed
to closely emulate every aspect of smoking a traditional cigarette.
From the cigarette-style packaging and stick format, to the
proprietary flavouring blend which imparts the flavour and scent of
tobacco, to the draw sensation, and the amount of smoke exhaled,
Beyond Tobacco™ has been meticulously engineered to enable smokers
to continue enjoying the ritual of smoking, while discontinuing
nicotine intake. Taat plans to launch Beyond Tobacco™ in mid-Q4
2020 and is seeking to position itself in the USD $814 billion
(2018)1 global tobacco industry to capitalize on the growing
worldwide demand for alternatives to traditional cigarettes.
For more information, please visit http://taatusa.com.
References
1 British American Tobacco - The Global Market
Forward Looking Statements
This news release contains “forward-looking information” within
the meaning of applicable Canadian securities legislation. Often,
but not always, forward-looking information and information can be
identified by the use of words such as “plans”, “expects” or “does
not expect”, “is expected”, “estimates”, “intends”, “anticipates”
or “does not anticipate”, or “believes”, or variations of such
words and phrases or state that certain actions, events or results
“may”, “could”, “would”, “might” or “will” be taken, occur, or be
achieved. Forward-looking information in this news release includes
statements regarding the potential launch of Beyond Tobacco™. The
forward-looking information reflects management’s current
expectations based on information currently available and are
subject to a number of risks and uncertainties that may cause
outcomes to differ materially from those discussed in the
forward-looking information. Although the Company believes that the
assumptions and factors used in preparing the forward-looking
information are reasonable, undue reliance should not be placed on
such information and no assurance can be given that such events
will occur in the disclosed timeframes or at all. Factors that
could cause actual results or events to differ materially from
current expectations include: (i) adverse market conditions; (ii)
changes to the growth and size of the tobacco markets; and (iii)
other factors beyond the control of the Company. The Company
operates in a rapidly evolving environment. New risk factors emerge
from time to time, and it is impossible for the Company’s
management to predict all risk factors, nor can the Company assess
the impact of all factors on Company’s business or the extent to
which any factor, or combination of factors, may cause actual
results to differ from those contained in any forward-looking
information. The forward-looking information included in this news
release are made as of the date of this news release and the
Company expressly disclaims any intention or obligation to update
or revise any forward-looking information whether as a result of
new information, future events or otherwise, except as required by
applicable law.
The statements in this news release have not been evaluated by
Health Canada or the U.S. Food and Drug Administration. As each
individual is different, the benefits, if any, of taking the
Company’s products will vary from person to person. No claims or
guarantees can be made as to the effects of the Company’s products
on an individual’s health and well-being. The Company’s products
are not intended to diagnose, treat, cure, or prevent any
disease.
This news release may contain trademarked names of third-party
entities (or their respective offerings with trademarked names)
typically in reference to (i) relationships had by the Company with
such third-party entities as referred to in this release and/or
(ii) client/vendor/service provider parties whose relationship with
the Company is/are referred to in this release. All rights to such
trademarks are reserved by their respective owners or
licensees.
Statement Regarding Third-Party Investor Relations
Firms
Disclosures relating to investor relations firms retained by
Taat Lifestyle & Wellness Ltd. can be found under the Company's
profile on http://sedar.com.
TAAT Global Alternatives (CSE:TAAT)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
TAAT Global Alternatives (CSE:TAAT)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024